Ivermectin and fenbendazole are today two of the loudest keywords in the online “alternative health” current. Thousands of videos, posts and groups circulate under the word “protocol”, in which both agents — antiparasitic drugs by origin — are presented as a way of treating serious disease in humans. The phenomenon is worth understanding, because it affects real health decisions. Below we explain where it came from, what exactly these posts claim, and what science says about it.
Fenbendazole — the story that lit the fire
Fenbendazole's online popularity grew largely from one widely shared story from 2019 — the account of a man with advanced lung cancer who attributed his improvement to a dog dewormer. The story spread instantly and gave rise to a whole community sharing similar “protocols”.
An important detail usually missing from those videos: the man in that story was at the same time taking part in a clinical trial of a modern, experimental cancer therapy and was taking other drugs as well. It is therefore impossible to say that fenbendazole alone helped him — a single case without a comparison group proves nothing. In science this is called an anecdote, not evidence.
Ivermectin — from a Nobel Prize to a pandemic
Ivermectin has a genuinely earned reputation: its discovery won the 2015 Nobel Prize, and the drug has protected millions of people from parasitic disease (river blindness among them). That good name meant that when a laboratory cell study appeared in 2020 suggesting an effect on the coronavirus, the news spread at once.
The problem is that the study used doses many times higher than can safely be achieved in the body. Later large, rigorous human trials (including TOGETHER and ACTIV-6) showed no meaningful benefit of ivermectin in COVID-19. The online trend nonetheless took on a life of its own.
What claims circulate online
The material under these tags consists above all of personal testimony and claims that both compounds help with conditions such as cancer, viral infections, Lyme disease or “general immune support”. For the record — and for the reader's safety — here is how they compare with what is actually known:
- Cancer: there are preliminary cell studies, but no human trials confirming efficacy. This is a hypothesis to be tested, not a treatment.
- COVID-19 and viral infections: large human trials did not confirm a benefit; the regulators (FDA, EMA) advised against such use.
- Lyme disease and others: no reliable human studies; the claims rest on individual anecdotes.
- “Immunity” and prevention: marketing slogans with no support in the research on these compounds.
Why such content spreads so fast
- A moving story persuades more than dry numbers — one affecting account carries more weight than a table of trial results.
- Algorithms promote content that stirs emotion, regardless of whether it is true.
- Distrust of institutions — some people treat “forbidden” content as more credible.
- A grain of truth — real, preliminary studies get over-interpreted and presented as a finished therapy.
Real, documented dangers
This is not a harmless fashion. Concrete harms are described in the medical literature and health data:
- Liver injury — cases of serious liver damage have been reported in people who took fenbendazole and related agents on their own.
- Ivermectin poisoning — during the pandemic, poison centres recorded more overdose reports, including with preparations meant for animals.
- Dangerous interactions — both compounds can react hazardously with other drugs.
- The most dangerous of all: delaying proper treatment — replacing a proven therapy (cancer treatment, for instance) with something bought online can cost a life.
How to read such content sensibly
A few questions worth asking of any “protocol” found online:
- Is this one person's story, or a proper study with a comparison group?
- Is the author selling a product or earning from the reach?
- Has the claim been confirmed by independent human trials, or only by cell studies?
- What do the official regulators say (FDA, EMA, national agencies)?
On matters of health, always talk to a doctor. Do not stop prescribed treatment in favour of something found online.
In summary: the ivermectin and fenbendazole trend is a fascinating example of how science, individual anecdotes and social media blend into a single viral message. Treat it as a curiosity about the phenomenon — not as health guidance.
Sources
- Caly L. et al. (2020), The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, Antiviral Research — doi.org/10.1016/j.antiviral.2020.104787
- Reis G. et al. / the TOGETHER trial (2022), Effect of Early Treatment with Ivermectin among Patients with Covid-19, NEJM — nejm.org
- The ACTIV-6 trial (2022), Effect of Ivermectin on Time to Recovery in Outpatients with COVID-19, JAMA — pubmed.ncbi.nlm.nih.gov
- FDA, Why You Should Not Use Ivermectin to Treat or Prevent COVID-19 — fda.gov
- Dogra N. et al. (2018), Fenbendazole acts as a moderate microtubule destabilizing agent…, Scientific Reports — nature.com
SWISS LAB products are reagents intended for in-vitro laboratory research only. They are not for human consumption and are not for treatment.